Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

March 10, 2022

Conditions
Ulcerative Colitis
Interventions
DRUG

Probiotic Formula Capsule

The Probiotic will be coded in a specific label by a researcher who will not be in contact with the participants and administrated randomly based on gender in a double-blind manner. The patient will receive 2 bottles of the drug every 2 weeks and will be followed weekly for 6 weeks.

DRUG

Placebos

The Placebos will be coded in a specific label by a researcher who will not be in contact with the participants and administrated randomly based on gender in a double-blind manner. The patient will receive 2 bottles of the placebo every 2 weeks and will be followed weekly for 6 weeks.

Trial Locations (1)

Unknown

Jordan University Hospital, Amman

All Listed Sponsors
lead

University of Jordan

OTHER

NCT04223479 - Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan | Biotech Hunter | Biotech Hunter